DALLAS — Oct. 11, 2010 — A clinical trial at UT Southwestern Medical Center aims to determine whether adding the hormone leptin to standard insulin therapy might help rein in the tumultuous blood-sugar levels of people with type 1 (insulin-depen…
In women with metabolic syndrome, blood levels of C-reactive protein (CRP) can help predict cardiovascular risk, researchers reported today in Circulation: Journal of the American Heart Association. CRP is an indicator of inflammation. High levels of CRP have been linked to increased risk of heart attack, stroke, and type 2 (non-insulin dependent) diabetes.
People with insulin-dependent (type-1) diabetes have an increased risk of dying from a stroke, according to first-time findings from a large, community-based study reported in today’s rapid access issue of Stroke: Journal of the American Heart Association. Cardiovascular disease is already recognized as the main cause of long-term complications and death in patients with diabetes. The likelihood of death from cerebrovascular disease ? related to the blood supply in the brain and the No. 1 cause of stroke ? has not been previously reported for patients with type-1 diabetes. Previous studies have shown that cerebrovascular death rates are raised in patients with type-2 diabetes (non?insulin-dependent diabetes).